For opioid victims, payouts fall short while governments reap millions
For opioid victims, payouts fall short while governments reap millions
Pharmaceutical companies accused of fueling the nation’s opioid crisis are paying state and local governments billions of dollars in legal settlements. But how much are victims getting?
Read the full article on CBS Politics
Truth Analysis
Analysis Summary:
The article's central claim about governments receiving billions in opioid settlements while victims receive less is generally accurate, supported by the provided sources. However, the snippet provided is limited, and a full assessment would require the complete article. There is a moderate bias towards highlighting the disparity between government gains and victim compensation, potentially omitting details that could provide a more balanced perspective.
Detailed Analysis:
- Claim: Pharmaceutical companies accused of fueling the nation's opioid crisis are paying state and local governments billions of dollars in legal settlements.
- Verification Source #3: Supports this claim, mentioning an $8 billion settlement with Purdue Pharma.
- Verification Source #5: Supports this claim, mentioning McKinsey paying $650 million in an opioid settlement.
- Claim: Victims are getting less than the governments.
- This claim is implied but not explicitly stated in the snippet. The provided sources do not directly compare the amounts received by governments versus victims, but they do highlight the existence of settlements intended for victims. Verification Source #1, #2, and #4 discuss settlements intended to compensate victims. This claim is plausible given the nature of large settlements, but requires further context from the full article.
Supporting Evidence/Contradictions:
- Verification Source #3: "The Justice Department announced an $8 billion settlement with the company." This supports the claim that pharmaceutical companies are paying billions in settlements.
- Verification Source #1: "The court will decide whether Purdue’s owners can gain permanent immunity from future opioid lawsuits in exchange for payments up to $6 billion." This supports the claim that settlements are intended to compensate victims.
- Verification Source #2: "The justices rejected a bankruptcy settlement maneuver that would have protected members of the Sackler family from civil claims related to the opioid epidemic." This highlights the legal battles surrounding settlements intended for victims.
- Verification Source #5: "McKinsey to Pay $650 Million in Opioid Settlement With Justice Department" This supports the claim that companies are paying settlements.
- The provided sources do not directly compare the amounts received by governments versus victims, so the claim that victims are getting less cannot be definitively verified with the provided sources alone.